REVISTA SAÚDE - UNG-Ser
Open Journal Systems
Ajuda do sistema
Usuário
Login
Senha
Lembrar usuário
Idioma
Selecione o idioma
English
Español (España)
Português (Brasil)
Conteúdo da revista
Pesquisa
Escopo da Busca
Todos
Autor
Título
Resumo
Termos indexados
Texto Completo
Procurar
Por Edição
Por Autor
Por título
Outras revistas
Tamanho de fonte
Informações
Para leitores
Para Autores
Para Bibliotecários
Capa
Sobre
Acesso
Cadastro
Pesquisa
Atual
Anteriores
Notícias
Resumos de teses
Capa
>
DENTAL BLEACHING: CASE REPORTS THAT ACHIEVED AESTHETICS RESULTS IN DENTISTRY WITH AT-HOME BLEACHING SYSTEMS
>
Comentários do leitor
>
BRIEF-Walgreens Boots Alliance Reports Fiscal...
Comentários do leitor
BRIEF-Walgreens Boots Alliance Reports Fiscal 2024 First Quarter...
por
Cecila Sweetapple
(23/03/2024)
Jan 4 (Reuters)
- Walgreens
Boots Alliance Inc:
* WALGREENS BOOTS ALLIANCE REPORTS FISCAL 2024 FIRST QUARTER RESULTS
* ANNOUNCING A 48 PERCENT REDUCTION IN QUARTERLY DIVIDEND PAYMENT TO $0.25 PER SHARE
* U.S. RETAIL PHARMACY SEGMENT HAD Q1 SALES OF $28.9 BILLION, AN INCREASE OF 6.4 PERCENT FROM YEAR-AGO QUARTER
* MAINTAINING FY2024 U.S. HEALTHCARE ADJUSTED EBITDA TO BE BREAKEVEN AT MIDPOINT OF GUIDANCE RANGE OF NEGATIVE $50 MILLION TO $50 MILLION
* EVALUATING STRATEGIC OPTIONS TO DRIVE SUSTAINABLE LONG-TERM SHAREHOLDER VALUE, SWIFT ACTIONS TO RIGHT-SIZE COSTS,
asesoria
INCREASE CASH FLOW
* FY2024 EARNINGS PER SHARE VIEW $3.32, REVENUE VIEW $143.00 BILLION -- LSEG IBES DATA
* Q1 RESULTS INCLUD $278 MILLION AFTER-TAX CHARGE Source text for Eikon: Further company coverage:
1)
UnG - Universidade Guarulhos
2)
Indexador: Latindex
3)
Indexador: Dialnet
BRIEF-Walgreens Boots Alliance Reports Fiscal 2024 First Quarter...
por Cecila Sweetapple (23/03/2024)
* WALGREENS BOOTS ALLIANCE REPORTS FISCAL 2024 FIRST QUARTER RESULTS
* ANNOUNCING A 48 PERCENT REDUCTION IN QUARTERLY DIVIDEND PAYMENT TO $0.25 PER SHARE
* U.S. RETAIL PHARMACY SEGMENT HAD Q1 SALES OF $28.9 BILLION, AN INCREASE OF 6.4 PERCENT FROM YEAR-AGO QUARTER
* MAINTAINING FY2024 U.S. HEALTHCARE ADJUSTED EBITDA TO BE BREAKEVEN AT MIDPOINT OF GUIDANCE RANGE OF NEGATIVE $50 MILLION TO $50 MILLION
* EVALUATING STRATEGIC OPTIONS TO DRIVE SUSTAINABLE LONG-TERM SHAREHOLDER VALUE, SWIFT ACTIONS TO RIGHT-SIZE COSTS, asesoria INCREASE CASH FLOW
* FY2024 EARNINGS PER SHARE VIEW $3.32, REVENUE VIEW $143.00 BILLION -- LSEG IBES DATA
* Q1 RESULTS INCLUD $278 MILLION AFTER-TAX CHARGE Source text for Eikon: Further company coverage: